[ad_1] HONG KONG, Feb. 5, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/AK112-306) evaluating ivonescimab, its independently […]
Tag: Inc.
Rollick Announces New Enhancements, Integrations, and Continued Industry Adoption for RollickEngage
[ad_1] AUSTIN, Texas and LAS VEGAS, Feb. 5, 2025 /PRNewswire/ — Rollick, a leader in digital marketing solutions for the outdoor recreation, marine, powersports, commercial, and industrial industries, announced today at AIMExpo that RollickEngage, its […]
Etsy to Announce Fourth Quarter and Year End 2024 Financial Results on February 19, 2025
[ad_1] BROOKLYN, N.Y., Feb. 5, 2025 /PRNewswire/ — Etsy, Inc. (Nasdaq: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, plans to release its fourth quarter […]
BMI Highlights Digital Land Record Solutions At 2025 Geomatics Conference
[ad_1] The BMI team showcased its innovative digital solutions for historic land records at the 2025 CSU Fresno Geomatics Conference, connecting with professionals dedicated to advancing land surveying practices. SUNNYVALE, Calif., Feb. 5, 2025 /PRNewswire/ […]
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
[ad_1] BIZENGRI® is the first and only FDA-approved therapy specifically for patients with advanced unresectable or metastatic pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) who harbor NRG1 gene fusions1 NRG1 gene fusions are best detected by […]
